Mersana Therapeutics, Inc. (MRSN)
29.08
0.00 (0.00%)
USD |
NASDAQ |
Jan 13, 16:00
Mersana Therapeutics Gross Profit (Quarterly): 10.93M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | -0.028M |
| Day One Biopharmaceuticals, Inc. | 35.32M |
| Semler Scientific, Inc. | 6.855M |
| Cue Biopharma, Inc. | 2.07M |
| Scholar Rock Holding Corp. | -0.423M |